M10
Bioanalytical Method Validation and Study Sample Analysis
Current edition
Step 4, 24 May 2022
Current edition
Step 4, 24 May 2022
About this standard
Gives recommendations for validating bioanalytical methods that measure chemical and biological drugs, and for using them to analyze study samples.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
- United StatesImplemented
- Edition accepted
- -
- National code
- Vol. 87, No. 214, Docket No. FDA-2019-D-1469, p. 67037-67039
Effective November 7, 2022
- European UnionImplemented
- Edition accepted
- -
- National code
- EMA/CHMP/ICH/172948/2019
Effective January 21, 2023
- JapanImplemented
- Edition accepted
- -
- National code
- PSB/PED Notification No. 1204-1
Effective December 4, 2024
- ChinaImplemented
- Edition accepted
- -
- National code
- NMPA, China Announcement No.16(2023)
Effective July 29, 2023
- BrazilImplemented
- Edition accepted
- -
- National code
- Guideline nº 72/2024, RESOLUÇÃO RDC Nº 941, DE 18 DE NOVEMBRO DE 2024
Effective November 18, 2024
- South KoreaImplemented
- Edition accepted
- -
- National code
- Guidelines on Bioanalytical Method Validation and Study Sample Analysis
Effective October 26, 2023
- SwitzerlandImplemented
- Edition accepted
- -
- National code
- -
Effective May 25, 2022. ICH guidelines apply in Switzerland automatically once they reach Step 4.
- SingaporeImplemented
- Edition accepted
- -
- National code
- -
Not yet on the HSA list of adopted ICH guidelines (page updated 1 June 2026).
- TaiwanImplemented
- Edition accepted
- -
- National code
- Updated-Announcement for ICH Guidelines Recognition List
Effective May 30, 2023
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
United States
- Bioequivalence studies with pharmacokinetic endpoints for generic drugsBioequivalence · Not stated
European Union
- Conduct of bioequivalence studies: GCP, GMP of study products and bioanalysisBioequivalence · Not stated
United Kingdom
- Bioequivalence: ICH guidelines implemented by the MHRABioequivalence · Not stated
Japan
- Validation of analytical methodsAnalytical method validation · Not stated
Canada
- Design and conduct of comparative bioavailability and bioequivalence studiesBioequivalence · Not stated
Related standards: FDA analytical procedures guidance, Q2(R2), USP <1224>, USP <1225>, USP <1226>, USP <621>, Q14, ASEAN analytical validation guideline, RDC 166/2017, Taiwan analytical validation manual. See all standards.